{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T16:22:11Z","timestamp":1783009331117,"version":"3.54.5"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008376","name":"HUS Helsinki University Hospital","doi-asserted-by":"publisher","award":["TYH2020206"],"award-info":[{"award-number":["TYH2020206"]}],"id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017400","name":"Finnish Cancer Institute sr","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017400","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.cgh.2026.05.005","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:08:11Z","timestamp":1778760491000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Time-Dependent Prognostic Score (Helsinki Primary Sclerosing Cholangitis Score) to Predict Disease Outcomes in Primary Sclerosing Cholangitis"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0250-8559","authenticated-orcid":false,"given":"Martti","family":"F\u00e4rkkil\u00e4","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Bergquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Molinaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Tenca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Middelburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyriel","family":"Ponsioen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannu","family":"Kautiainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2026.05.005_bib1","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1053\/j.gastro.2021.07.046","article-title":"Defining primary sclerosing cholangitis: results from an international primary sclerosing cholangitis study group consensus process","volume":"161","author":"Ponsioen","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2026.05.005_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.05.005_bib3","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population based epidemiology, malignancy, risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.05.005_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cld.2015.08.014","article-title":"Cancer risk and surveillance in primary sclerosing cholangitis","volume":"20","author":"Folseraas","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cgh.2026.05.005_bib5","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/00365521.2019.1707277","article-title":"Epidemiology, risk of malignancy and patient survival in primary sclerosing cholangitis: a population-based study in Finland","volume":"55","author":"Barner-Rasmussen","year":"2020","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2026.05.005_bib6","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weismuller","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2026.05.005_bib7","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.29882","article-title":"Design and endpoints for clinical trials in primary sclerosing cholangitis","volume":"68","author":"Ponsioen","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.05.005_bib8","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","article-title":"EASL Clinical Practice Guidelines on sclerosing cholangitis","volume":"77","author":"Chazouilleres","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.05.005_bib9","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/apt.16296","article-title":"Systematic review: non-invasive prognostic tests for primary sclerosing cholangitis","volume":"53","author":"Mazhar","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2026.05.005_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.dld.2010.12.008","article-title":"Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis","volume":"43","author":"Stanich","year":"2011","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2026.05.005_bib11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jhep.2012.10.013","article-title":"Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis","volume":"58","author":"Al Mamari","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.05.005_bib12","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1111\/liv.13110","article-title":"Alkaline phosphatase at diagnosis of primary sclerosing cholangitis and 1 year later: evaluation of prognostic value","volume":"36","author":"de Vries","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2026.05.005_bib13","article-title":"The performance of enhanced liver fibrosis (ELF) test for the staging of liver fibrosis: a meta-analysis","volume":"9","author":"Xie","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2026.05.005_bib14","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1111\/liv.13402","article-title":"Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multicentre study","volume":"37","author":"de Vries","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2026.05.005_bib15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/hep.27825","article-title":"Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis","volume":"62","author":"Vesterhus","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.05.005_bib16","article-title":"Fluctuating biomarkers in primary sclerosing cholangitis: a longitudinal comparison of alkaline phosphatase, liver stiffness, and ELF","volume":"3","author":"Fossdal","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.cgh.2026.05.005_bib17","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/apt.16153","article-title":"Anti-glycoprotein 2 (anti-GP2) IgA and anti-neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3-ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitis","volume":"53","author":"Wunsch","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2026.05.005_bib18","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0025-6196(11)64614-4","article-title":"Al. A revised natural history model for primary sclerosing cholangitis","volume":"75","author":"Kim","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cgh.2026.05.005_bib19","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/hep.30479","article-title":"Factors associated with outcomes of patients with primary sclerosing cholangitis and development and validation of a risk scoring system","volume":"69","author":"Goode","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.05.005_bib20","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1136\/gutjnl-2016-313681","article-title":"A novel prognostic model for transplant-free survival in primary sclerosing cholangitis","volume":"67","author":"De Vries","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2026.05.005_bib21","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/hep.30085","article-title":"Primary sclerosing cholangitis risk estimate tool (PREsTo) predicts outcomes of the disease: a derivation and validation study using machine learning","volume":"71","author":"Eaton","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.05.005_bib22","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.05.005_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2023.11729","article-title":"Liver transplantation for primary sclerosing cholangitis (PSC) with or without inflammatory bowel disease (IBD) - a European Society of Organ transplantation (ESOT) consensus statement","volume":"36","author":"Carbone","year":"2023","journal-title":"Transpl Int"},{"key":"10.1016\/j.cgh.2026.05.005_bib24","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/hep.28256","article-title":"Surrogate endpoints for clinical trials in primary sclerosing cholangitis: review and results from an International PSC Study Group consensus process","volume":"63","author":"Ponsioen","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.05.005_bib25","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1055\/a-2511-3422","article-title":"Surveillance of PSC: comparison of scheduled or on-demand ERCP with annual MRI\/MRCP surveillance. A multicentre study","volume":"57","author":"Barner-Rasmussen","year":"2025","journal-title":"Endoscopy"},{"key":"10.1016\/j.cgh.2026.05.005_bib26","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1055\/s-0041-110792","article-title":"Screening primary sclerosing cholangitis and biliary dysplasia with endoscopic retrograde cholangiography and brush cytology: risk factors for biliary neoplasia","volume":"48","author":"Boyd","year":"2016","journal-title":"Endoscopy"},{"key":"10.1016\/j.cgh.2026.05.005_bib27","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/00365521.2016.1250281","article-title":"Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma","volume":"52","author":"Boyd","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2026.05.005_bib28","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jhep.2022.11.011","article-title":"Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis","volume":"78","author":"Villard","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.05.005_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102526","article-title":"The Swedish initiative for the study of Primary sclerosing cholangitis (SUPRIM)","volume":"70","author":"Cornillet","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.cgh.2026.05.005_bib30","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/liv.15471","article-title":"Disease burden in primary sclerosing cholangitis in the Netherlands: a long-term follow-up study","volume":"43","author":"van Munster","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2026.05.005_bib31","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple non-invasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.05.005_bib32","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.crohns.2012.09.003","article-title":"Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis","volume":"6","author":"Dignass","year":"2012","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2026.05.005_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjw168","article-title":"3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: part 1: diagnosis and medical management","volume":"11","author":"Gomoll\u00f3n","year":"2017","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2026.05.005_bib34","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2017.02.013","article-title":"Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline","volume":"66","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.05.005_bib35","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.0006-341X.2000.00337.x","article-title":"Time-dependent ROC curves for censored survival data and a diagnostic marker","volume":"56","author":"Heagerty","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.cgh.2026.05.005_bib36","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/sim.6360","article-title":"Optimal survival time-related cut-point with censored data","volume":"34","author":"Liu","year":"2015","journal-title":"Stat Med"},{"key":"10.1016\/j.cgh.2026.05.005_bib37","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.neucom.2020.07.061","article-title":"On hyperparameter optimization of machine learning algorithms: theory and practice","volume":"415","author":"Yang","year":"2020","journal-title":"Neurocomputing"},{"key":"10.1016\/j.cgh.2026.05.005_bib38","article-title":"A comprehensive benchmark of machine and deep learning across diverse tabular datasets","author":"Shmuel","year":"2024","journal-title":"arXiv"},{"key":"10.1016\/j.cgh.2026.05.005_bib39","series-title":"Stata 19 machine learning in stata using H2O: Ensemble decision trees reference manual","year":"2025"},{"key":"10.1016\/j.cgh.2026.05.005_bib40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1572-0241.2006.00872.x","article-title":"Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study","volume":"102","author":"Tischendorf","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2026.05.005_bib41","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jhep.2019.06.012","article-title":"Validation, clinical utility and limitations of the Amsterdam-Oxford model for primary sclerosing cholangitis","volume":"71","author":"Goet","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.05.005_bib42","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.05.005_bib43","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1111\/liv.13899","article-title":"The role of magnetic resonance imaging and endoscopic retrograde cholangiography in the evaluation of disease activity and severity in primary sclerosing cholangitis","volume":"38","author":"Tenca","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2026.05.005_bib44","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1055\/s-0043-107029","article-title":"Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline","volume":"49","author":"Aabakken","year":"2017","journal-title":"Endoscopy"},{"key":"10.1016\/j.cgh.2026.05.005_bib45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1148\/radiol.10091953","article-title":"Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography","volume":"256","author":"Maneesh","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.cgh.2026.05.005_bib46","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/liv.15286","article-title":"Impact on follow-up strategies in patients with primary sclerosing cholangitis","volume":"43","author":"Bergquist","year":"2023","journal-title":"Liver Int"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356526003551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356526003551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:45:42Z","timestamp":1783007142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356526003551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":46,"alternative-id":["S1542356526003551"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2026.05.005","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Time-Dependent Prognostic Score (Helsinki Primary Sclerosing Cholangitis Score) to Predict Disease Outcomes in Primary Sclerosing Cholangitis","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2026.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Gastroenterological Association Institute. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}